rbs target $1.31

Snippet from ninemsn money

"FN Arena Broker Call Headlines - 11 Nov 2009 11/11/2009 11:15:02 AM

RBS Australia rates (CXS.AX , 0.885, +0.005, +0.570%) as Buy - Target $1.31 (was $0.91). The broker notes the US FDA has granted priority review for Omapro, which suggests approval is likely by March next year. The broker has lifted its valuation and price target on the news and this supports its Buy rating, the next catalyst likely to be a European marketing partner that could be announced by year end. More"


I'm not a subscriber so don't know what the more bit says.

link is-

http://money.ninemsn.com.au/article.aspx?id=969704